Coley Pharmaceutical Group
Wellesley
About Coley Pharmaceutical Group
Coley Pharmaceutical Group operates as a biopharmaceutical company developing therapeutics and drug candidates that direct the human immune system to fight cancers, asthma and allergy, autoimmune disorders, and to enhance the effectiveness of vaccines. The company was formerly known as CpG ImmunoPharmaceuticals, Inc. and in August 2000 it changed its name to Coley Pharmaceutical Group, Inc. The company was founded in 1997 and is based in Wellesley, Massachusetts. As of December 28, 2007, Coley Pharmaceutical Group, Inc. operates as a subsidiary of Pfizer Inc.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $85.1M
- Funding stage: M&A
- Last round: Post-IPO Equity (Feb 2007)
- Ticker: nasdaq:COLY
- Website: coleypharma.com
- Phone: (781)431-9000
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/coley-pharmaceutical-group-2288845 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.